Dahiyat Bassil I

Avg. Two Year Performance

No purchase track record
(50%) Avg. Sale Return
(22%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(10%)(23%)(19%)(4%)(50%)
Sale Success Rate0 of 50 of 52 of 52 of 51 of 5
Drugs » Biotechnology

PRESIDENT & CEO, Director:

Holdings: 352.62K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--